13 Most Promising Penny Stocks Under $5

Page 10 of 12

3. Rocket Pharmaceuticals Inc. (NASDAQ:RCKT)

Share Price as of August 15: $3.12

Number of Hedge Fund Holders: 40

Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) is one of the most promising penny stocks under $5. On July 24, Rocket Pharmaceuticals announced a strategic corporate reorganization and pipeline prioritization to focus its resources on its adeno-associated virus/AAV cardiovascular platform and the regulatory submission for KRESLADI (formerly RP-L201) for severe leukocyte adhesion deficiency-I/LAD-I.

The company is implementing a workforce reduction of ~30%. This, along with other cost-saving measures, is expected to decrease Rocket’s 12-month operating expenses by ~25%. As a result, the company anticipates that its current cash resources will fund operations into Q2 2027.

This estimate does not account for any potential proceeds from a Priority Review Voucher, which may be granted upon the FDA approval of KRESLADI. As part of this realignment, the company anticipates delays in the Fanconi Anemia (FA; RP-L102) and Pyruvate Kinase Deficiency (PKD; RP-L301) programs, with FDA approval for RP-L102 no longer expected in 2026.

Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases in the US.

Page 10 of 12